Summary of Significant Accounting Policies (Tables)
|
9 Months Ended |
Sep. 30, 2022 |
|---|
| Accounting Policies [Abstract] |
|
| Schedule of goodwill activity |
| |
|
CBR Goodwill |
|
|
180T Goodwill |
|
|
Consolidated Goodwill |
|
| |
|
|
|
|
|
|
|
|
|
| Balance, December 31, 2021 |
|
$ |
23,749,631 |
|
|
$ |
13,238,255 |
|
|
$ |
36,987,886 |
|
| Currency translation |
|
|
(664,353 |
) |
|
|
- |
|
|
|
(664,353 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, March 31, 2022 |
|
|
23,085,278 |
|
|
|
13,238,255 |
|
|
|
36,323,533 |
|
| Currency translation |
|
|
(1,734,582 |
) |
|
|
- |
|
|
|
(1,734,582 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, June 30, 2022 |
|
|
21,350,696 |
|
|
|
13,238,255 |
|
|
|
34,588,951 |
|
| Currency translation |
|
|
(1,750,386 |
) |
|
|
- |
|
|
|
(1,750,386 |
) |
| Balance before impairment |
|
|
19,600,310 |
|
|
|
13,238,255 |
|
|
|
32,838,565 |
|
| Impairment of goodwill |
|
|
(11,264,612 |
) |
|
|
(7,608,238 |
) |
|
|
(18,872,850 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, September 30, 2022 |
|
$ |
8,335,698 |
|
|
$ |
5,630,017 |
|
|
$ |
13,965,715 |
|
|
| Schedule of reconciles between basic and diluted weighted average shares outstanding |
| |
|
For the Three Months Ended
September 30, |
|
|
For the Nine Months Ended
September 30, |
|
| |
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
| Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
| Net (loss) income |
|
$ |
(21,486,978 |
) |
|
$ |
18,296,856 |
|
|
$ |
(16,983,981 |
) |
|
$ |
(21,360,865 |
) |
| Less: decrease in fair value of dilutive warrants |
|
|
- |
|
|
|
10,487,783 |
|
|
|
- |
|
|
|
- |
|
| (Loss) income available to common stockholders - diluted |
|
$ |
(21,486,978 |
) |
|
$ |
7,809,073 |
|
|
$ |
(16,983,981 |
) |
|
$ |
(21,360,865 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average shares outstanding (denominator for basic earnings per share) |
|
|
39,181,736 |
(1) |
|
|
32,727,965 |
|
|
|
35,803,504 |
(1) |
|
|
30,491,082 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Effects of dilutive securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Assumed exercise of stock options, treasury stock method |
|
|
- |
|
|
|
182,727 |
|
|
|
- |
|
|
|
- |
|
| Assumed exercise of warrants, treasury stock method |
|
|
- |
|
|
|
798,892 |
|
|
|
- |
|
|
|
- |
|
| Dilutive potential common shares |
|
|
- |
|
|
|
981,619 |
|
|
|
- |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average shares and assumed potential common shares (denominator for diluted earnings per share, treasury method) |
|
|
39,181,736 |
(1) |
|
|
33,709,584 |
|
|
|
35,803,504 |
(1) |
|
|
30,491,082 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic earnings per share |
|
$ |
(0.55 |
) |
|
$ |
0.56 |
|
|
$ |
(0.47 |
) |
|
$ |
(0.70 |
) |
| Diluted earnings per share |
|
$ |
(0.55 |
) |
|
$ |
0.23 |
|
|
$ |
(0.47 |
) |
|
$ |
(0.70 |
) |
|
| Schedule of anti dilutive common shares |
| |
|
For the Three Months Ended
September 30, |
|
|
For the Nine Months Ended
September 30, |
|
| |
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
| Options |
|
|
3,259,121 |
|
|
|
436,000 |
|
|
|
3,259,121 |
|
|
|
2,066,000 |
|
| Warrants |
|
|
17,285,984 |
(1) |
|
|
8,526,250 |
|
|
|
17,285,984 |
(1) |
|
|
11,153,908 |
|
| Total potentially dilutive shares |
|
|
20,545,105 |
|
|
|
8,962,250 |
|
|
|
20,545,105 |
|
|
|
13,219,908 |
|
|